(Q48855216)

16 February 2018

title

CSF levels of diazepam-binding inhibitor correlate with REM latency in schizophrenia, a pilot study. (English)

1 reference

16 February 2018

0 references

1 reference

D P van Kammen

1

1 reference

16 February 2018

A Guidotti

2

1 reference

16 February 2018

T Neylan

3

1 reference

16 February 2018

P Guarneri

4

1 reference

16 February 2018

M E Kelley

5

1 reference

16 February 2018

J Gurklis

6

1 reference

16 February 2018

M W Gilbertson

7

1 reference

16 February 2018

J L Peters

8

1 reference

16 February 2018

E Costa

9

1 reference

16 February 2018

publication date

1 January 1994

1 reference

16 February 2018

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

16 February 2018

volume

244

1 reference

16 February 2018

issue

4

1 reference

16 February 2018

page(s)

216-222

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1007/bf02190401

exact match

0 references

cites work

Negative symptoms in schizophrenia. Definition and reliability

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia, and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Effectiveness of Temazepam with Short-, Intermediate-, and Long-Term Use: Sleep Laboratory Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Flurazepam effects on sleep EEG. Visual, computer, and cycle analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Distribution of a putative endogenous modulator of the GABAergic system in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Further evidence of abnormal non-rapid-eye-movement sleep in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Diazepam in schizophrenia: a preliminary double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Sleep EEG studies in untreated, long-term schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Two roads to rapid eye movement latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Delta sleep ratio. A biological correlate of early recurrence in unipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Amino acid sequence of acyl-CoA-binding protein from cow liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Sleep disturbance in schizophrenia. A revisit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Electroencephalographic sleep in psychotic depression. A valid subtype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Sleep Stage Deficits in Chronic Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Benzodiazepines in the treatment of schizophrenia: a review and reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Acute high-dose parenteral haloperidol treatment of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02190401

Sleep in schizophrenic patients on and off haloperidol therapy. Clinically stable vs relapsed patients

21 January 2018

1 reference

12 December 2020

Benzodiazepine receptors in the central nervous system

1 reference

12 December 2020

Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors

1 reference

12 December 2020

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor

1 reference

12 December 2020

In vitro conversion of pregnenolone to progesterone by discrete brain areas of the male rat

1 reference

12 December 2020

The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis.

1 reference

12 December 2020

Decreased slow-wave sleep and enlarged lateral ventricles in schizophrenia.

1 reference

12 December 2020

Effects of muscimol and flurazepam on the sleep EEG in the rat.

1 reference

12 December 2020

The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor.

1 reference

12 December 2020

Electroencephalographic sleep in schizophrenia: a critical review

1 reference

12 December 2020

Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard

1 reference

12 December 2020

Hypnotics and sleep physiology: a consensus report. European Sleep Research Society, Committee on Hypnotics and Sleep Physiology

1 reference

12 December 2020

Effects of peptides (DSIP, DSIP analogues, VIP, GRF and CCK) on sleep in the rat.

1 reference

12 December 2020

Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics

1 reference

12 December 2020

Diazepam in high doses is effective in schizophrenia.

1 reference

12 December 2020

CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal

1 reference

12 December 2020

Sleep EEG variables in young schizophrenic and depressive patients.

1 reference

12 December 2020

Isolation and characterization of a rat brain triakontatetraneuropeptide, a posttranslational product of diazepam binding inhibitor: specific action at the Ro 5-4864 recognition site.

1 reference

12 December 2020

Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates

1 reference

12 December 2020

Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor

1 reference

12 December 2020

The search for the hypnogenic center

1 reference

12 December 2020

Delta sleep-inducing-peptide-like immunoreactivity (DSIP-LI) and delta sleep in schizophrenic volunteers

1 reference

12 December 2020

Electroencephalographic and eye movement patterns during sleep in chronic schizophrenic patients.

1 reference

12 December 2020

CSF chromogranin A-like immunoreactivity in schizophrenia: Relationships with REM latency and slow wave sleep

1 reference

12 December 2020

Progesterone 5 alpha-reductase in mouse brain.

1 reference

12 December 2020

Association between abnormal REM sleep and negative symptoms in schizophrenia.

1 reference

12 December 2020

FURTHER OBSERVATIONS ON ELECTROPHYSIOLOGICAL SLEEP PATTERNS IN SCHIZOPHRENIA

1 reference

12 December 2020

Diazepam-binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain.

1 reference

12 December 2020

Interleukin 1 alters rat sleep: temporal and dose-related effects.

1 reference

12 December 2020

Diazepam binding inhibitor (DBI): a peptide with multiple biological actions

1 reference

12 December 2020

Methods for reliable longitudinal observation of behavior

1 reference

12 December 2020

Lorazepam as an adjunct in the treatment of auditory hallucinations in a schizophrenic patient

1 reference

12 December 2020

[3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics

1 reference

12 December 2020

Isolation and characterization of porcine diazepam-binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin release

1 reference

12 December 2020

Dopamine and norepinephrine activity in schizophrenia. An integrative perspective

1 reference

12 December 2020

A diazepam binding inhibitor (DBI)-like neuropeptide is detected in human brain

1 reference

12 December 2020

CSF diazepam binding inhibitor and schizophrenia: clinical and biochemical relationships

1 reference

12 December 2020

Effects of moclobemide on sleep in healthy human subjects.

1 reference

12 December 2020

Modulation of benzodiazepine receptor binding in mouse brain by adrenalectomy and steroid replacement.

1 reference

12 December 2020

Abnormal rapid eye movement latencies in schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02190401

1 reference

16 February 2018

1 reference

16 February 2018